Cargando…

Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice

Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance. The peroxisome proliferator-activated receptor (PPAR) activators, thiazolidinediones, (TZDs), are insulin sensitizers used as a treatment for NAFLD. However, TZDs are a controversial treatment for NAFLD because...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choung, Sorim, Joung, Kyong Hye, You, Bo Ram, Park, Sang Ki, Kim, Hyun Jin, Ku, Bon Jeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020545/ https://www.ncbi.nlm.nih.gov/pubmed/30008738 http://dx.doi.org/10.1155/2018/4292509

Ejemplares similares

Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice
por: Choung, Sorim, et al.
Publicado: (2019)

Effects of lobeglitazone on insulin resistance and hepatic steatosis in high-fat diet-fed mice
por: Choi, Bong-Hoi, et al.
Publicado: (2018)

Serum Soluble Epidermal Growth Factor Receptor Level Increase in Patients Newly Diagnosed with Type 2 Diabetes Mellitus
por: Kim, Ji Min, et al.
Publicado: (2018)

Association between IL-1beta and cardiovascular disease risk in patients with newly diagnosed, drug-naïve type 2 diabetes mellitus: a cross-sectional study
por: Joung, Kyong Hye, et al.
Publicado: (2020)

Soluble LRIG2 is a potential biomarker for type 2 diabetes mellitus
por: Kim, Ji Min, et al.
Publicado: (2021)

Clinical Implications of Using Post-Challenge Plasma Glucose Levels for Early Diagnosis of Type 2 Diabetes Mellitus in Older Individuals
por: Joung, Kyong Hye, et al.
Publicado: (2018)

Amelioration of Hypercholesterolemia by an EGFR Tyrosine Kinase Inhibitor in Mice with Liver-Specific Knockout of Mig-6
por: Lee, Jun Choul, et al.
Publicado: (2014)

The Role of Circulating Slit2, the One of the Newly Batokines, in Human Diabetes Mellitus
por: Kang, Yea Eun, et al.
Publicado: (2017)

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter
por: Lee, Hye Won, et al.
Publicado: (2017)

Mentha canadensis attenuates adiposity and hepatic steatosis in high-fat diet-induced obese mice
por: Han, Youngji, et al.
Publicado: (2023)

Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ
por: Jang, Jun Young, et al.
Publicado: (2018)

Lobeglitazone Attenuates Airway Inflammation and Mucus Hypersecretion in a Murine Model of Ovalbumin-Induced Asthma
por: Shin, Na-Rae, et al.
Publicado: (2018)

Sasa borealis Stem Extract Attenuates Hepatic Steatosis in High-Fat Diet-induced Obese Rats
por: Song, Yuno, et al.
Publicado: (2014)

Oxygenated Water Inhibits Adipogenesis and Attenuates Hepatic Steatosis in High-Fat Diet-Induced Obese Mice
por: Cheng, Yuh-Jen, et al.
Publicado: (2020)

Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats
por: Li, Mao, et al.
Publicado: (2016)

IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis
por: Gao, Yinjie, et al.
Publicado: (2016)

White Pitaya (Hylocereus undatus) Juice Attenuates Insulin Resistance and Hepatic Steatosis in Diet-Induced Obese Mice
por: Song, Haizhao, et al.
Publicado: (2016)

Naringenin attenuates hepatitis B virus X protein-induced hepatic steatosis
por: Lin, Hung-Jen, et al.
Publicado: (2017)

Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice
por: Bae, Kwi-Hyun, et al.
Publicado: (2017)

Serum CD14 concentration is associated with obesity and insulin resistance in non-diabetic individuals
por: Kang, Yea Eun, et al.
Publicado: (2022)

Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liver
por: Seo, Hye-Young, et al.
Publicado: (2023)

The Association between Type 2 Diabetes Mellitus and Women Cancer: The Epidemiological Evidences and Putative Mechanisms
por: Joung, Kyong Hye, et al.
Publicado: (2015)

Fructus Xanthii Attenuates Hepatic Steatosis in Rats Fed on High-Fat Diet
por: Li, Xiumin, et al.
Publicado: (2013)

Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
por: Kern, Matthias, et al.
Publicado: (2012)

Impaired Cardiolipin Biosynthesis Prevents Hepatic Steatosis and Diet-Induced Obesity
por: Cole, Laura K., et al.
Publicado: (2016)

The Roles of Adipokines, Proinflammatory Cytokines, and Adipose Tissue Macrophages in Obesity-Associated Insulin Resistance in Modest Obesity and Early Metabolic Dysfunction
por: Kang, Yea Eun, et al.
Publicado: (2016)

Mig-6 Gene Knockout Induces Neointimal Hyperplasia in the Vascular Smooth Muscle Cell
por: Lee, Ju Hee, et al.
Publicado: (2014)

Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice
por: Kim, Kyoung Min, et al.
Publicado: (2017)

(Pro)Renin Receptor Antagonism Attenuates High-Fat-Diet–Induced Hepatic Steatosis
por: Gayban, Ariana Julia B., et al.
Publicado: (2023)

Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study
por: Lim, Soo, et al.
Publicado: (2020)

Ursolic Acid Attenuates Hepatic Steatosis, Fibrosis, and Insulin Resistance by Modulating the Circadian Rhythm Pathway in Diet-Induced Obese Mice
por: Kwon, Eun-Young, et al.
Publicado: (2018)

Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis
por: Yoo, Jeongin, et al.
Publicado: (2020)

Feasibility of Ultrasound Attenuation Imaging for Assessing Pediatric Hepatic Steatosis
por: Song, Kyungchul, et al.
Publicado: (2022)

Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
por: Bae, Jaehyun, et al.
Publicado: (2021)

Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects
por: Kim, Heeyoung, et al.
Publicado: (2023)

Lobeglitazone Exerts Anti-Inflammatory Effect in Lipopolysaccharide-Induced Bone-Marrow Derived Macrophages
por: Jeong, Dabin, et al.
Publicado: (2021)

Serum R-Spondin 1 Is a New Surrogate Marker for Obesity and Insulin Resistance
por: Kang, Yea Eun, et al.
Publicado: (2019)

KBH-1, an herbal composition, improves hepatic steatosis and leptin resistance in high-fat diet-induced obese rats
por: Lee, Ji-Hye, et al.
Publicado: (2016)

Hepatic glucose utilization in hepatic steatosis and obesity
por: Keramida, Georgia, et al.
Publicado: (2016)

Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice
por: Kim, Kyung Eun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5doe294dp2014ok1qdf02igmag